NAFDAC approves Pfizer COVID-19 for use in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of Pfizer COVID-19 in Nigeria.

The Director-General of the agency, Mojisola Adeyeye announced this during a virtual meeting on Friday in Abuja, explaining that the vaccine is for emergency use.

The NAFDAC’s approval is coming a few months after it gave a nod for the use of the Oxford-Astrazeneca jabs
Nigeria had in March received 3.9 million doses of the Astranezeneca jabs and flagged off the vaccination exercise in Abuja.

Leave a Reply

Your email address will not be published. Required fields are marked *